Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Apolipoprotein D anticorps

APOD Reactivité: Humain ELISA Hôte: Souris Monoclonal D544 unconjugated
N° du produit ABIN6963942
  • Antigène Voir toutes Apolipoprotein D (APOD) Anticorps
    Apolipoprotein D (APOD)
    Reactivité
    • 32
    • 22
    • 20
    • 15
    Humain
    Hôte
    • 41
    • 6
    • 2
    Souris
    Clonalité
    • 43
    • 6
    Monoclonal
    Conjugué
    • 23
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Apolipoprotein D est non-conjugé
    Application
    • 34
    • 15
    • 13
    • 13
    • 12
    • 8
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    ELISA
    Specificité
    Apolipoprotein D
    Purification
    Purified from in vitro cultures by protein G affinity chromatography.
    Immunogène
    Recombinant human apoD
    Clone
    D544
    Isotype
    IgG1
    Top Product
    Discover our top product APOD Anticorps primaire
  • Indications d'application
    For quantification of apoD in serum/ plasma samples and cell culture supernatants using ELISA. D544 is recommended as coating mAb in combination with detection mAb D263 .
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5 mg/mL
    Buffer
    supplied at 0.5 mg/mL in PBS with 0.02 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.
    Date de péremption
    18 months
  • Kuiperij, Hondius, Kersten, Versleijen, Rozemuller, Greenberg, Schreuder, Klijn, Verbeek: "Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy." dans: Neuropathology and applied neurobiology, Vol. 46, Issue 5, pp. 431-440, (2020) (PubMed).

    Herzig, Leppäluoto, Jokelainen, Meugnier, Pesenti, Selänne, Mäkelä, Ahola, Jämsä, Vidal, Keinänen-Kiukaanniemi: "Low level activity thresholds for changes in NMR biomarkers and genes in high risk subjects for Type 2 Diabetes." dans: Scientific reports, Vol. 7, Issue 1, pp. 11267, (2019) (PubMed).

    Braesch-Andersen, Beckman, Paulie, Kumagai-Braesch: "ApoD mediates binding of HDL to LDL and to growing T24 carcinoma." dans: PLoS ONE, Vol. 9, Issue 12, pp. e115180, (2016) (PubMed).

  • Antigène
    Apolipoprotein D (APOD)
    Autre désignation
    apoD (APOD Produits)
    Synonymes
    anticorps APOD, anticorps apod, anticorps zgc:153593, anticorps AOPDGN, anticorps Apo-D, anticorps lipocalin, anticorps apolipoprotein D, anticorps apolipoprotein Da, duplicate 1, anticorps APOD, anticorps CpipJ_CPIJ006492, anticorps CpipJ_CPIJ017615, anticorps CpipJ_CPIJ020105, anticorps apod, anticorps apoda.1, anticorps Apod
    ID gène
    347
    Pathways
    Platelet-derived growth Factor Receptor Signaling
Vous êtes ici:
Support technique